Fasken advised BioTwin in connection with this transaction.On April 8, 2021, BioTwin, a Quebec-based biotechnology company, announced the completion of their pre-seed funding round. The company…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
